Cambridge Nutritional Science (CNSL)

Sector:

Health Care

Index:

FTSE AIM All-Share

 3.25p
   
  • Change Today:
      0.000p
  • 52 Week High: 4.35
  • 52 Week Low: 2.54
  • Currency: UK Pounds
  • Shares Issued: 237.95m
  • Volume: 40,555
  • Market Cap: £7.73m

Cambridge Nutritional Sciences total income seen higher in FY25

By Iain Gilbert

Date: Tuesday 27 May 2025

LONDON (ShareCast) - (Sharecast News) - Medical diagnostics company Cambridge Nutritional Sciences said on Tuesday that total income was expected to be up double digits in the year ended 31 March.
Cambridge Nutritional said total income was expected to be roughly £11.1m, representing a 12% increase on the prior year, including £2.5m of exceptional income recognised as a result of the successful outcome from its DHSC settlement. However, revenue excluding exceptional and other income was £8.3m, down from £9.8m in FY24.

Gross profit margins were seen at approximately 65%, up from 61.9% a year earlier, while adjusted underlying earnings were expected to have doubled to £400,000 and pre-tax profits were seen at £1.6m, improving from FY24's pre-tax loss of £750,000. Net cash balances slipped by £500,000 to £4.9m.

Looking forward, Cambridge Nutritional said the new financial year had "started positively" as its growing revenue pipeline started to flow through, which it said was "early evidence" of the more target focused delivery of the revenue strategy for FY26 and was aided by a solid sales position completed in the UK in FY25.

Chief executive James Cooper said: "I am pleased with our performance in 2025, delivering good solid profit even before we see the benefit of our new sales pipeline coming through its long sales cycle. It is a very exciting time for food sensitivity testing in a global market when gut health diagnostics are showing signs of growth. I want to personally thank all our people and acknowledge all their hard work and effort in the last year. Looking forward, Cambridge Nutritional Sciences is in a very strong position from a product and team perspective, with significant cash resources and the prospects for revenue and profitability growth in 2026 and beyond."

As of 1020 BST, Cambridge Nutritional shares had rallied 15.51% to 3.29p.





Reporting by Iain Gilbert at Sharecast.com

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

CNSL Market Data

Currency UK Pounds
Share Price 3.25p
Change Today 0.000p
% Change 0.00 %
52 Week High 4.35
52 Week Low 2.54
Volume 40,555
Shares Issued 237.95m
Market Cap £7.73m

CNSL Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
3.12% above the market average3.12% above the market average3.12% above the market average3.12% above the market average3.12% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Price Trend
13.21% above the market average13.21% above the market average13.21% above the market average13.21% above the market average13.21% above the market average
29.73% above the sector average29.73% above the sector average29.73% above the sector average29.73% above the sector average29.73% above the sector average
Income Not Available
Growth
22.17% above the market average22.17% above the market average22.17% above the market average22.17% above the market average22.17% above the market average
2.86% below the sector average2.86% below the sector average2.86% below the sector average2.86% below the sector average2.86% below the sector average

CNSL Dividends

No dividends found

Trades for 04-Jun-2025

Time Volume / Share Price
08:49 8,657 @ 3.12p
08:05 31,898 @ 3.14p

Top of Page